Author(s): Nataki Duncan MPH, MHS, Meharry Medical College, USA; Dr Libby Whittaker, DermNet Staff Writer, New Zealand (2023) Previous contributors: Dr Amanda Oakley, Dermatologist (2002) Reviewing dermatologist: Dr Ian Coulson
Skin infections can be caused by bacteria (often Staphylococcal or Streptococcal) either invading normal skin, or affecting a compromised skin barrier (eg, skin affected by atopic dermatitis, or surgical wound sites).
The skin is our first line of protection against the environment. A local or systemic response is activated when this protective barrier is invaded. Microorganisms that invade the skin can be part of the external environment or the normal skin microbiome.
Honey-coloured crusts on the chin in impetigo
A swollen tender hot left leg due to Streptococcal cellulitis
Interdigital and toe pitted keratolysis
Ecthyma gangrenosum due to Pseudomonas septicaemia
Palmarerythematousmacules suggestive of secondary syphilis
Bacterial skin infections are a common reason for emergency visits. Children under five years and adults over 65 years old are affected more often than other age groups. In 2005, the World Health Organisation (WHO) reported a high prevalence of skin disease in children from developing countries in sub-Saharan Africa.
Gender may also play a role; in one North American study, men comprised 60-70% of all cases of cellulitis.
Certain comorbid conditions increase susceptibility to bacterial skin infections, such as diabetes, vascular insufficiency, and being immunocompromised (eg, chemotherapy patients with neutropaenia). Some people, such as those who inject drugs, are at increased risk. Among hospitalised patients, skin infections are prevalent and often complicate the hospital course.
What are the clinical features of bacterial skin infections?
Bacterial skin infections can result in diverse clinical presentations. Generally, they will present with erythema, pain, warmth, swelling, and, depending on severity, dysfunction.Purulentdischarge and lymphadenopathy may also be evident on examination.
In severe infections, the following signs may be present:
Temperature instability (higher than 38⁰C or lower than 35⁰C)
Tachycardia
Altered mental status
Rapid progression of infection
Haemorrhagic or violaceousbullae
Signs of necrosis
Crepitus.
How do clinical features vary in differing types of skin?
Optimising management of other medical conditions (eg, diabetic control).
Maintaining skin barrier (eg, through appropriate management of atopic dermatitis, and skin irritant/allergen avoidance).
What is the treatment for bacterial skin infections?
Minor bacterial infections often resolve without treatment. Due to increasing antibiotic resistance, first-line use of topical antibiotics, such as fusidic acid, is generally discouraged; topical antiseptics are often used as an alternative for minor infections. More serious or persistent bacterial infections are treated with oral, intravenous, or sometimes intramuscularantibiotics.
It is best to take samples (eg, swabs or blood cultures) to test which organism is responsible for an infection before commencing antibiotics. If the infection is serious (eg, suspected meningococcal disease), do not delay treatment with a broad-spectrum antibiotic. As culture and sensitivities become available, change to an appropriate narrow-spectrum antibiotic.
Antibiotics should not be prescribed if they are not indicated or unlikely to be of benefit, for example, if the infection is viral in origin. Adverse reactions include cutaneous effects and gastrointestinal side effects. Antibiotic stewardship is also an important consideration.
What is the outcome for bacterial skin infections?
Many bacterial skin infections resolve without treatment or without serious morbidity. However, skin infections can be severe and cause a significant burden of disease worldwide, sometimes resulting in sepsis and death, particularly in vulnerable patient groups such as the elderly, hospitalised, and immunocompromised.
Antibiotic resistance has increasing implications for the treatability and outcome of many bacterial skin infections moving forwards.
Ellis Simonsen SM, van Orman ER, Hatch BE, et al. Cellulitis incidence in a defined population. Epidemiol Infect. 2005;134(2):293–299. doi: 10.1017/S095026880500484X. Journal
Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;52 Suppl 1:i3–17. doi: 10.1093/jac/dkg466. Journal
Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clin Infect Dis. 2019;68(Suppl 3):S193–S199. doi: 10.1093/cid/ciz002. Journal
Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol. 2008;19(2):173–184. doi: 10.1155/2008/846453. Journal
Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am Fam Physician. 2002;66(1):119–124. Journal
World Health Organisation (WHO). Epidemiology and Management of Common Skin Diseases in Children in Developing Countries. WHO. Published December 1, 2005. Accessed March 20, 2023. Available here